Presse Medicale

Papers
(The median citation count of Presse Medicale is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial44
Editorial board42
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients36
Contents36
Kidney disease in multiple myeloma34
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification30
International variability in the diagnosis and management of disorders of consciousness27
Autoimmunity in lipodystrophy syndromes25
History of measles22
Editorial board20
Familial partial lipodystrophy syndromes20
New developments in skin-directed treatments of cutaneous T-cell lymphoma19
Craniopharyngiomas19
Editorial board18
Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma18
Editorial board18
Molecular Imaging in neuroendocrine neoplasias18
Pulmonary hypertension in sickle cell disease17
Editorial board16
Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma16
Prognosis of consciousness disorders in the intensive care unit16
Towards etiological treatments in cardiomyopathies16
Presentation of polymyalgia rheumatica and large joint polyarthritis in the spectrum of hyper-IgG4-related disease: A case report and literature review15
The current and future contribution of neuroimaging to the understanding of disorders of consciousness14
Cholera in Haiti14
The deep and the deeper: Spinal cord and deep brain stimulation for neuropathic pain13
Heart failure with preserved ejection fraction: New challenges and new hopes13
Heart failure: A major public health problem13
Cystic fibrosis13
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact12
Update on brain MRI for the diagnosis and follow-up of MS patients11
Cardiac functional imaging11
Editorial board11
Contents9
Contents9
Generalized lipoatrophy syndromes9
Adrenal functional imaging8
Contents8
Risk stratification of acute pulmonary embolism8
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”8
The Spanish flu8
Contents7
A tribute to Guy Meyer7
COVID-19 and kidney transplantation7
Sickle cell disease and pregnancy7
Imaging in multiple myeloma7
Metreleptin treatment of non-HIV lipodystrophy syndromes7
Prolactinomas7
Elderly patients with venous thromboembolism: Insights from the RIETE registry7
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments6
Idiopathic pulmonary fibrosis6
Rehabilitation in multiple sclerosis in 20216
Vascular pathophysiology of sickle cell disease6
Contents6
The liver in sickle cell disease5
Multiple sclerosis diagnostic criteria: From poser to the 2017 revised McDonald criteria5
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success4
Preventative and curative treatment of venous thromboembolic disease in cancer patients4
Health technology assessment in France4
New concepts on immunology of Multiple Sclerosis4
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management4
Diagnostic management of acute pulmonary embolism4
What's new in transplantation?4
Treatment of elderly and frail myeloma patients4
Life and death of smallpox4
Bronchiectasis4
Functional imaging in thyroid cancer patients with metastases and therapeutic implications4
Duration of anticoagulation of venous thromboembolism4
Recent insights in pituitary diseases3
Capillary malformations updates on aetiopathogenesis, diagnosis, and management3
Cushing's disease3
Editorial QMR vascular malformations3
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer3
The French way of HTA: Between scientific rigor, independence and transparency3
Primary ciliary dyskinesia3
Hypophysitis: A comprehensive overview3
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years3
Electrical therapies in heart failure: Evolving technologies and indications2
Neuropathic pain: Evidence based recommendations2
Molecular imaging or functional: An increasingly applied method in all fields of medicine2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?2
Patient-reported outcome measures: A key to patient-tailored and outcome-driven care in pulmonary embolism survivors2
Editorial2
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all2
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?2
Editorial2
Contents2
Multiple symmetric and multiple familial lipomatosis1
Yellow fever: A brief history of a tropical Virosis1
Chronic heart failure with reduced EF: A decade of major pharmacological innovations1
Covid-19, an unfinished story1
Lymphatic malformations revisited: genetics, clinics and future directions1
Laboratory-associated infections and biosafety1
Contents1
Gene-addition/editing therapy in sickle cell disease1
Editorial board1
French reimbursement of health technologies: assessment is at the heart of the procedure1
Taking ethics into account: the HAS perspective1
Contents1
Optimising recovery of consciousness after coma. From bench to bedside and vice versa1
Diagnostic criteria and etiopathogenesis of type 2 diabetes and its complications: Lessons from the Pima Indians1
End-stage heart failure: The future of heart transplant and artificial heart1
Lymphangioleiomyomatosis1
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas1
Editorial board1
Health technology assessment in Europe: A comparison of organizations and introduction to the European regulation1
Functional imaging for hyperparathyroidism1
Features of an adrenal cortical carcinoma on CT scan: A case report1
Fecal microbiota transplantation: History, procedure and regulatory considerations1
New immunosuppressive agents in transplantation1
Severity of kidney involvement as predictor of death, severe heart failure and renal events in patients with type 2 diabetes: Data from a prospective cohort1
The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease1
Editorial1
French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis1
0.34586191177368